Page 116 - Read Online

Schofield et al. J Cancer Metastasis Treat 2020;6:10 I http://dx.doi.org/10.20517/2394-4722.2019.43 Page 11 of 12

38. Zhang B, Wang Z, Deng B, Wu X, Liu J, et al. Identification of Enolase 1 and Thrombospondin-1 as serum biomarkers in HBV hepatic
fibrosis by proteomics. Proteome Sci 2013;11:30.
39. Feo S, Arcuri D, Piddini E, Passantino R, Giallongo A. ENO1 gene product binds to the c-myc promoter and acts as a transcriptional
repressor: relationship with Myc promoter-binding protein 1 (MBP-1). FEBS Lett 2000;473:47-52.
40. Bae SM, Min HJ, Ding GH, Kwak SY, Cho YL, et al. Protein expression profile using two-dimensional gel analysis in squamous cervical
cancer patients. Cancer Res Treat 2006;38:99-107.
41. Katayama M, Nakano H, Ishiuchi A, Wu W, Oshima R, et al. Protein pattern difference in the colon cancer cell lines examined by two-
dimensional differential in-gel electrophoresis and mass spectrometry. Surg Today 2006;36:1085-93.
42. Chang YS, Wu W, Walsh G, Hong WK, Mao L. Enolase-alpha is frequently down-regulated in non-small cell lung cancer and predicts
aggressive biological behavior. Clin Cancer Res 2003;9:3641-4.
43. Duijvesz D, Burnum-Johnson KE, Gritsenko MA, Hoogland AM, Vredenbregt-van den Berg MS, et al. Proteomic profiling of exosomes
leads to the identification of novel biomarkers for prostate cancer. PLoS One 2013;8:e82589.
44. Seweryn E, Pietkiewicz J, Bednarz-Misa IS, Ceremuga I, Saczko J, et al. Localization of enolase in the subfractions of a breast cancer cell
line. Z Naturforsch C J Biosci 2009;64:754-8.
45. He P, Naka T, Serada S, Fujimoto M, Tanaka T, et al. Proteomics-based identification of alpha-enolase as a tumor antigen in non-small
lung cancer. Cancer Sci 2007;98:1234-40.
46. Mears R, Craven RA, Hanrahan S, Totty N, Upton C, et al. Proteomic analysis of melanoma-derived exosomes by two-dimensional
polyacrylamide gel electrophoresis and mass spectrometry. Proteomics 2004;4:4019-31.
47. Greening DW, Ji H, Chen M, Robinson BW, Dick IM, et al. Secreted primary human malignant mesothelioma exosome signature reflects
oncogenic cargo. Sci Rep 2016;6:32643.
48. Pan D, Chen J, Feng C, Wu W, Wang Y, et al. Preferential localization of MUC1 glycoprotein in exosomes secreted by non-small cell
lung carcinoma cells. Int J Mol Sci 2019;20.
49. Valcz G, Galamb O, Krenacs T, Spisak S, Kalmar A, et al. Exosomes in colorectal carcinoma formation: ALIX under the magnifying
glass. Mod Pathol 2016;29:928-38.
50. Didiasova M, Schaefer L, Wygrecka M. When place matters: shuttling of enolase-1 across cellular compartments. Front Cell Dev Biol
2019;7:61.
51. Entelis N, Brandina I, Kamenski P, Krasheninnikov IA, Martin RP, et al. A glycolytic enzyme, enolase, is recruited as a cofactor of tRNA
targeting toward mitochondria in Saccharomyces cerevisiae. Genes Dev 2006;20:1609-20.
52. Brandina I, Graham J, Lemaitre-Guillier C, Entelis N, Krasheninnikov I, et al. Enolase takes part in a macromolecular complex associated
to mitochondria in yeast. Biochim Biophys Acta 2006;1757:1217-28.
53. Gao S, Li H, Cai Y, Ye JT, Liu ZP, et al. Mitochondrial binding of alpha-enolase stabilizes mitochondrial membrane: its role in
doxorubicin-induced cardiomyocyte apoptosis. Arch Biochem Biophys 2014;542:46-55.
54. Aaronson RM, Graven KK, Tucci M, McDonald RJ, Farber HW. Non-neuronal enolase is an endothelial hypoxic stress protein. J Biol
Chem 1995;270:27752-7.
55. Plow EF, Das R. Enolase-1 as a plasminogen receptor. Blood 2009;113:5371-2.
56. Lunt SY, Vander Heiden MG. Aerobic glycolysis: meeting the metabolic requirements of cell proliferation. Annu Rev Cell Dev Biol
2011;27:441-64.
57. Liu Y, Li H, Liu Y, Zhu Z. MiR-22-3p targeting alpha-enolase 1 regulates the proliferation of retinoblastoma cells. Biomed Pharmacother
2018;105:805-12.
58. Zhu X, Yu H, Li B, Quan J, Zeng Z, et al. Targetting an LncRNA P5848-ENO1 axis inhibits tumor growth in hepatocellular carcinoma.
Biosci Rep 2019;39.
59. Ji M, Wang Z, Chen J, Gu L, Chen M, et al. Up-regulated ENO1 promotes the bladder cancer cell growth and proliferation via regulating
beta-catenin. Biosci Rep 2019;39.
60. Sun L, Lu T, Tian K, Zhou D, Yuan J, et al. Alpha-enolase promotes gastric cancer cell proliferation and metastasis via regulating AKT
signaling pathway. Eur J Pharmacol 2019;845:8-15.
61. Liu YQ, Huang ZG, Li GN, Du JL, Ou YP, et al. Effects of alpha-enolase (ENO1) over-expression on malignant biological behaviors of
AGS cells. Int J Clin Exp Med 2015;8:231-9.
62. Capello M, Ferri-Borgogno S, Riganti C, Chattaragada MS, Principe M, et al. Targeting the Warburg effect in cancer cells through ENO1
knockdown rescues oxidative phosphorylation and induces growth arrest. Oncotarget 2016;7:5598-612.
63. Chen S, Zhang Y, Wang H, Zeng YY, Li Z, et al. WW domain-binding protein 2 acts as an oncogene by modulating the activity of the
glycolytic enzyme ENO1 in glioma. Cell Death Dis 2018;9:347.
64. Qiao H, Wang YF, Yuan WZ, Zhu BD, Jiang L, et al. Silencing of ENO1 by shRNA inhibits the proliferation of gastric cancer cells.
Technol Cancer Res Treat 2018;17:1533033818784411.
65. Syrovets T, Lunov O, Simmet T. Plasmin as a proinflammatory cell activator. J Leukoc Biol 2012;92:509-19.
66. Redlitz A, Fowler BJ, Plow EF, Miles LA. The role of an enolase-related molecule in plasminogen binding to cells. Eur J Biochem
1995;227:407-15.
67. Chen X, Xu H, Wu N, Liu X, Qiao G, et al. Interaction between granulin A and enolase 1 attenuates the migration and invasion of human
hepatoma cells. Oncotarget 2017;8:30305-16.
68. Principe M, Borgoni S, Cascione M, Chattaragada MS, Ferri-Borgogno S, et al. Alpha-enolase (ENO1) controls alpha v/beta 3 integrin
expression and regulates pancreatic cancer adhesion, invasion, and metastasis. J Hematol Oncol 2017;10:16.